Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma
Year: 2025
Type: article
Language: en
Topic: Multiple Myeloma Research and Treatments
Authors and affiliations:
raw_author_name: Frida Bugge Askeland
raw_affiliation_strings: Institute of Clinical Medicine, University of Oslo, Oslo, Norway. friask@ous-hf.no
Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway. friask@ous-hf.no
raw_author_name: Vilhelm Hauge Bugge
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
raw_author_name: Anne-Marie Rasmussen
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
raw_author_name: Anna Lysén
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
raw_author_name: Einar Haukås
raw_affiliation_strings: Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
raw_author_name: Magnus Moksnes
raw_affiliation_strings: Cancer and Hematology Center, Vestfold Hospital Trust, Tønsberg, Norway
raw_author_name: Anette L. Eilertsen
raw_affiliation_strings: Department of Hematology, Akershus University Hospital, Lørenskog, Norway
raw_author_name: Galina Tsykunova
raw_affiliation_strings: Department of Medicine, Haukeland University Hospital, Bergen, Norway
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
raw_author_name: Birgitte Dahl Eiken
raw_affiliation_strings: Department of Oncology and Hematology, Hospital Oestfold, Kalnes, Norway
raw_author_name: Nils Morten Leknes
raw_affiliation_strings: Department of Hematology, University Hospital of North Norway, Tromsø, Norway
raw_author_name: Jürgen Rolke
raw_affiliation_strings: Department of Hematology, Sørlandet Hospital, Kristiansand, Norway
raw_author_name: Vidar Stavseth
raw_affiliation_strings: Medical Department, Levanger Hospital, Levanger, Norway
raw_author_name: Eivind Samstad
raw_affiliation_strings: Department of Health Sciences in Ålesund, Norwegian University of Science and Technology, Ålesund, Norway
Department of Medicine, Ålesund Hospital, Ålesund, Norway
raw_author_name: Randi Fykse Hallstensen
raw_affiliation_strings: Department of Hematology, Nordland Hospital, Bodø, Norway
raw_author_name: Damian Szatkowski
raw_affiliation_strings: Department of Hematology and Oncology, Førde Central Hospital, Førde, Norway
raw_author_name: Ariane Aasbø Hansen
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
raw_author_name: Anita Smith Nilsen
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
raw_author_name: Tobias S. Slørdahl
raw_affiliation_strings: Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Department of Hematology, St. Olavs Hospital, Trondheim, Norway
raw_author_name: Pegah Abdollahi
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
raw_author_name: Fredrik Schjesvold
raw_affiliation_strings: Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway